Brief: Vanta Bioscience Expects Impact Of COVID-19 Pandemic On Co To Not Be Too Significant
22/05/2020 10:55
May 22 (Reuters) - Vanta Bioscience Ltd VANB.BO :
* EXPECTS IMPACT OF COVID-19 PANDEMIC WOULD NOT BE TOO
SIGNIFICANT
FOR CO
Source text for Eikon: ID:nBSE6Q72z3
Further company coverage: VANB.BO
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Vanta Bioscience
See all newsWellington-led funding boosts Vanta's valuation by 69% in a year (updated)
Advisory: Alert incorrectly tagged to Vanta Bioscience withdrawn
Brief: Vanta Expands Australia & New Zealand Presence With New Data Centre & Support For Additional Compliance Framework
Sequoia Capital-backed Vanta raises funding at $2.45 bln valuation (updated)
Brief: Vanta Bioscience Gets Order Worth 5.7 Million Rupees For GLP Studies